APA (7th ed.) Citation

E, N., M, G., K, A., B, A., A, A., N, A., . . . K, L. D. (2025). Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): A randomised controlled trial in Uganda. The Lancet. Global health, 13(1), e81. https://doi.org/10.1016/S2214-109X(24)00409-1

Chicago Style (17th ed.) Citation

E, Nakabembe, et al. "Safety and Immunogenicity of an Acellular Pertussis Vaccine Containing Genetically Detoxified Pertussis Toxin Administered to Pregnant Women Living with and Without HIV and Their Newborns (WoMANPOWER): A Randomised Controlled Trial in Uganda." The Lancet. Global Health 13, no. 1 (2025): e81. https://doi.org/10.1016/S2214-109X(24)00409-1.

MLA (9th ed.) Citation

E, Nakabembe, et al. "Safety and Immunogenicity of an Acellular Pertussis Vaccine Containing Genetically Detoxified Pertussis Toxin Administered to Pregnant Women Living with and Without HIV and Their Newborns (WoMANPOWER): A Randomised Controlled Trial in Uganda." The Lancet. Global Health, vol. 13, no. 1, 2025, p. e81, https://doi.org/10.1016/S2214-109X(24)00409-1.